[HTML][HTML] A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular …
Background T 1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …
A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance-the T1 Mapping and ECV Standardization in cardiovascular magnetic …
G Captur, P Gatehouse, KE Keenan… - Journal of …, 2016 - edoc.mdc-berlin.de
BACKGROUND: T1 mapping and extracellular volume (ECV) have the potential to guide
patient care and serve as surrogate end-points in clinical trials, but measurements differ …
patient care and serve as surrogate end-points in clinical trials, but measurements differ …
A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance-the T1 Mapping and ECV Standardization in cardiovascular magnetic …
G Captur, P Gatehouse, KE Keenan… - … : Official Journal of the …, 2016 - europepmc.org
Background T 1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …
[PDF][PDF] A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular magnetic …
G Captur, P Gatehouse, KE Keenan, FG Heslinga… - 2016 - ris.utwente.nl
Background: T1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …
A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular magnetic …
G Captur, P Gatehouse, K Keenan… - Journal of …, 2016 - research.utwente.nl
Background T1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …
[HTML][HTML] A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular …
G Captur, P Gatehouse, KE Keenan… - Journal of …, 2016 - Springer
Background T 1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …
[PDF][PDF] A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular magnetic …
G Captur, P Gatehouse, KE Keenan, FG Heslinga… - 2016 - tsapps.nist.gov
Background: T1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …
[HTML][HTML] A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance—the T1 Mapping and ECV Standardization in cardiovascular …
G Captur, P Gatehouse, KE Keenan… - Journal of …, 2016 - ncbi.nlm.nih.gov
Background T 1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …
A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance-the T1 Mapping and ECV Standardization in cardiovascular magnetic …
G Captur, P Gatehouse, K Keenan… - JOURNAL OF …, 2016 - boa.unimib.it
Background: T1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …
A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance-the T1 Mapping and ECV Standardization in cardiovascular magnetic …
G Captur, P Gatehouse, KE Keenan… - Journal of …, 2016 - search.proquest.com
Background T1 mapping and extracellular volume (ECV) have the potential to guide patient
care and serve as surrogate end-points in clinical trials, but measurements differ between …
care and serve as surrogate end-points in clinical trials, but measurements differ between …